MIF and breast cancer: Also, a significant elevation in serum MIF level was revealed in BC patients with curative and metastatic stages in contrast to control females, with p values < 0.0001 and < 0.0001 respectively, while no notable difference in serum MIF levels was demonstrated between BC cases with curative and metastatic stages (Fig. 2B).